How Much Do We Gain by Reducing Time to Reperfusion Therapy?
- 19 December 1996
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (12), 8-15
- https://doi.org/10.1016/s0002-9149(96)00737-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Time from symptom onset to treatment and outcomes after thrombolytic therapyJournal of the American College of Cardiology, 1996
- Epidemiology of Avoidable Delay in the Care of Patients With Acute Myocardial Infarction in ItalyArchives of Internal Medicine, 1995
- Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial ReperfusionCirculation, 1995
- Reasons Patients With Chest Pain Delay or Do Not Call 911Annals of Emergency Medicine, 1995
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Determinants of infarct size in reperfusion therapy for acute myocardial infarction.Circulation, 1992
- Paradoxical increase in restenosis rate with chronic heparin use: Final results of a randomized trialJournal of the American College of Cardiology, 1991
- Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysisJournal of the American College of Cardiology, 1990
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977